MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Alpha 1-Antitrypsin Deficiency

  1. Home
  2. Diseases
  3. Alpha 1-Antitrypsin Deficiency
  4. Clinical Trials

Clinical Trials Related to Alpha 1-Antitrypsin Deficiency

Related studies linked through entity extraction aliases.

NCT00295061

Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults

Status
COMPLETED
Phase
PHASE3

NCT00263887

Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)

Status
COMPLETED
Phase
PHASE2

NCT00242385

Pharmacokinetic Study of ARALAST (Human Alpha1- PI)

Status
COMPLETED
Phase
PHASE1

NCT00067756

4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?

Status
COMPLETED
Phase
PHASE2

NCT00005098

Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency

Status
TERMINATED
Phase
N/A

NCT00001462

Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals

Status
COMPLETED
Phase
N/A
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.